A variety of phenotypic cellular changes emerge in the liver of different species prior to the appearance of hepatocellular adenomas and carcinomas induced by carcinogenic agents (chemicals, radiation, hepadna viruses) or develop “spontaneously.” Foci of altered hepatocytes have been studied most extensively in rats treated with chemical carcinogens; they are considered preneoplastic lesions and have been used in several laboratories as endpoints in carcinogenicity testing. The principles and problems of the morphological classification of foci of altered hepatocytes are presented. In addition to the 4 types of foci generally accepted (clear, acidophilic, basophilic and mixed cell foci), further subtypes (intermediate cell foci) or other types of foci, namely tigroid cell foci and amphophilic cell foci, have more recently been separated as distinct pathomorphological entities. Whereas the amphophilic foci might result from a modulation of clear and acidophilic cell foci, the tigroid cell foci apparently represent a stage in a separate cell lineage leading to hepatocellular adenomas. It remains open whether the tigroid cell foci may also progress to carcinomas. Extrafocal phenotypic changes of hepatocytes might also be involved in hepatocarcinogenesis. The cellular phenotypes within foci also depend strongly, among many other factors, on the dose and duration of the carcinogenic treatment. Cytomorphological, cytochemical, microbiochemical and stereological studies suggest that the predominant sequence of cellular changes during hepatocarcinogenesis leads from the clear and acidophilic cell foci storing glycogen in excess through mixed cell foci and nodules to basophilic cell populations prevailing in hepatocellular carcinomas. A multitude of metabolic aberrations is associated with the sequential cellular changes. Aberrations in carbohydrate metabolism are particularly prominent and might be causally related to the neoplastic transformation of the hepatocytes.
BannaschP (1968). The cytoplasm of hepatocytes during carcinogenesis. Light and electron microscopic investigations of the nitrosomorpholine-intoxicated rat liver. Rec. Res. Cancer Res.19: 1–100.
2.
BannaschP (1986). Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis7: 689–695.
3.
BannaschPMüLlerH-A (1964). Lichtmikroskopische Untersuchungen über die Wirkung von N-Nitrosomorpholin auf die Leber von Ratte und Maus. Arzneim. Forsch.14: 805–814.
4.
BannaschPZerbanH (1989). Tumours of the liver. In: Pathology of Tumours in Laboratory Animals, 2nd ed., Tumours of the Liver in the Rat. International Agency for Research on Cancer, Lyon (in press).
5.
BannaschPMayerDHackerHJ (1980). Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim. Biophys. Acta605: 217–245.
6.
BannaschPMooreMAKlimekFZerbanH (1982). Biological markers of preneoplastic foci and neoplastic nodules in rodent liver. Toxicol. Pathol.10: 19–34.
7.
BannaschPHackerHJKlimekFMayerD (1984). Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Advan. Enzyme Regul.22: 97–121.
8.
BannaschPBennerUEnzmannHHackerHJ (1985). Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1Carcinogenesis6: 1641–1648.
9.
BannaschPZerbanHHackerHJ (1985). Foci of altered hepatocytes, rat. In: Monographs on Pathology of Laboratory Animals, Digestive System, JonesTCMohrUHuntRD (eds). Springer-Verlag, Berlin, Heidelberg, New York and Tokyo, pp. 10–30.
10.
BannaschPEnzmannHRuanYWeberEZerbanH (1988). Cellular differentiation during neoplastic development in the liver. In: Experimental Hepatocarcinogenesis, RoberfroidMBPréAtV (eds). Plenum Publishing Corp., New York, pp. 89–103.
11.
BannaschPEnzmannHHackerHJWeberEZerbanH (1989). Comparative pathobiology of hepatic preneoplasia. In: Liver Cell Carcinoma, BannaschPKepplerDWeberG (eds). MTP Press, Lancaster, pp. 53–73.
12.
BröZelU (1989). Hepatozelluläre Tumoren bei angeborener Glykogenspeicherkrankheit, Thesis, Universität Heidelberg.
13.
BuchmannAKuhlmannWSchwarzMKunzWWolfCRMollEFriedbergTOeschF (1985). Regulation and expression of four cytochrome P-450 isoenzymes, NADP-cytochrome P-450 reductase, the glutathione transferase B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis6: 513–521.
14.
CoireCIQizilbashAHCastelliMF (1987). Hepatic adenomata in type $Ia glycogen storage disease. Arch. Pathol. Lab. Med.111: 166–169.
15.
EhemannVMayerDHackerHJBannaschP (1986). Loss of adenylate cyclase activity in preneoplastic and neoplastic lesions induced in rat liver by N-nitrosomorpholine. Carcinogenesis7: 567–573.
16.
EnzmannHBannaschP (1987). Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis8: 1607–1612.
17.
EnzmannHBannaschP (1987). Morphometric study of alterations of extrafocal hepatocytes of rat liver treated with N-nitrosomorpholine. Virchows Arch. B (Cell Pathol.)53: 218–226.
18.
EnzmannHEdlerLBannaschP (1987). Simple elementary method for the quantification of focal liver lesions induced by carcinogens. Carcinogenesis8: 231–235.
19.
EnzmannHDettlerTOhlhauserDBannaschP (1988). Elevation of glucose-6-phosphate in early stages of hepatocarcinogenesis induced in rats by N-nitrosomorpholine. Horm. Metabol. Res.20: 128–129.
20.
EnzmannHOhlhauserDEnzmannHDettlerTBennerUHackerHJBannaschP (1989). Unusual histochemical pattern in preneoplastic hepatic foci characterized by hyperactivity of several enzymes. Virchows Arch. B (Cell Pathol.)57: 99–108.
21.
FarberE (1956). Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine,2-acetylaminofluorene and 3î-methyl-4-dimethylaminoazobenzene. Cancer Res.16: 142–148.
22.
FarberE (1982). The biology of carcinogen-induced hepatocyte nodules and related liver lesions in the rat. Toxicol. Pathol.10: 197–205.
23.
FarberE (1984). Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lecture. Cancer Res.44: 5463–5474.
24.
FarberESarmaDSR (1987). Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest.56: 4–22.
25.
FischerGDomingoMLodderDKatzNReinacherMEigenbrodtE (1987). Immunohistochemical demonstration of decreased L-pyruvate kinase in enzyme altered rat liver lesions produced by different carcinogens. Virchows Arch. B (Cell Pathol.)53: 359–364.
26.
FischerGRuschenburgJEigenbrodtEKatzN (1987). Decrease in glucokinase and glucose-6-phos-phatase and increase in hexokinase in putative preneoplastic lesions of rat liver. J. Cancer Res. Clin. Oncol.113: 430–436.
27.
GöSsnerWFriedrich-FreksaH (1964). Histochemische Untersuchungen über die Glucose-6-Phosphatase in der Rattenleber während der Cancerisierung durch Nitrosamine. Z. Naturforsch.19b: 862–864.
28.
GoldsworthyTLPitotHC (1985). The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Carcinogenesis6: 1261–1269.
29.
GoldsworthyTCampbellHAPitotHC (1984). The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis5: 67–71.
30.
GoldsworthyTLHaniganHMPitotHC (1986). Models of hepatocarcinogenesis in the rat-Contrasts and comparisons. CRC Crit. Rev. Toxicol.17: 61–89.
31.
HackerHJMooreMAMayerDBannaschP (1982). Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis3: 1265–1272.
32.
HowellRRStevensonREBen-MenachemYPhylikyRLBerryDH (1976). Hepatic adenomata with type 1 glycogen-storage disease. J. Am. Med. Assoc.236: 1481–1484.
33.
KalengayiMMRDesmetVJ (1975). Sequential histological and histochemical study of the rat liver during aflatoxin B1-induced carcinogenesis. Cancer Res.35: 2845–2852.
34.
KlimekFBannaschP (1989). Biochemical microcanalysis of α-glucosidase activity in preneoplastic hepatic lesions induced in rats by N-nitrosomorpholine. Virchows Arch. B (Cell Pathol.)57: 245–250.
35.
KlimekFMayerDBannaschP (1984). Biochemical microanalysis of glycogen content and glucoses-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine. Carcinogenesis5: 265–268.
KlimekFMooreMASchneiderEBannaschP (1988). Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver. Histochemistry90: 37–42.
38.
LimmerJFleigWELeupoldDBittnerRDitschuneitHBegerH-G (1988). Hepatocellular carcinoma in type 1 glycogen storage disease. Hepatology8: 531–537.
39.
MayerDLetschI (1989). Glucose 6-phosphate plays a central role in glycogen accumulation in a glycogen-storing rat liver cell line. Cell Biochem. Funct.7: 243–256.
40.
MayerDKlimekFHackerHJSeelmann-EggebertGBannaschP (1989). Carbohydrate metabolism in hepatic preneoplasia. In: Liver Cell Carcinoma, BannaschPKepplerDWeberG (eds). MTP Press, Lancaster, pp. 321–337.
41.
MooreMAKitagawaT (1986). Hepatocarcinogenesis in the rat; the effect of the promoters and carcinogens in vivo and in vitro. Int. Rev. Cytol.101: 125–173.
42.
MooreMAMayerDBannaschP (1982). The dose-dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis3: 1429–1436.
43.
MooreMANakamuraTShiraiTItoN (1986). Immunohistochemical demonstration of increased glucose-6-phosphate dehydrogenase in preneoplastic and neoplastic lesions induced by propylnitrosamines in F 344 rats and Syrian hamsters. Jpn. J. Cancer Res. (Gann)11: 131–138.
44.
MooreMATsudaHItoN (1986). Dehydrogenase histochemistry of N-ethyl-N-hydroxyethyl-nitrosamine-induced focal liver lesions in the rat-Increase in NADPH-generating capacity. Carcinogenesis1: 339–342.
45.
PaniPDessiSRaoKNBetettaBLaconiE (1984). Changes in serum and hepatic cholesterol in lead-induced liver hyperplasia. Toxicol. Pathol.12: 162–167.
46.
PerainoCStaffeldtEFCarnesBALudemanVABlomquistJAVesselinovitchSD (1984). Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res.44: 3340–3347.
47.
PerainoCCarnesBAStevensFJStaffeldtEFRusselJJPrapuolenisABlomquistJAVesselinovitchSDMaronpotRR (1988). Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats. Cancer Res.48: 4171–4178.
48.
PereiraMA (1982). Rat liver foci bioassay. J. Amer. Coll. Toxicol.1: 101–117.
49.
RabesHM (1988). Cell proliferation and hepatocarcinogenesis. In: Experimental Hepatocarcinogenesis, RoberfroidMBPréAtV (eds). Plenum Press, New York, London, pp. 121–132.
50.
RoberfroidMBPréAtV, (eds.) (1988). Experimental Hepatocarcinogenesis. Plenum Press, New York, London.
51.
SatoK (1988). Glutathione S-transferases and hepatocarcinogenesis. Jpn. J. Cancer Res. (Gann)79: 556–572.
52.
SatoKKitaharaASatohKIshikawaTTatematsuMItoN (1984). The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical carcinogenesis. Gann75: 199–202.
53.
SchauerAKunzeE (1968). Enzymhistochemische und autoradiographische Untersuchungen während der Kanzerisierung der Rattenleber durch Diäthylnitrosamin. Z. Krebsforsch.70: 252–266.
54.
SchererE (1981). Use of a programmable pocket calculator for the quantitation of precancerous foci. Carcinogenesis2: 805–807.
Seelmann-EggebertGMayerDMeckeDBannaschP (1987). Expression and regulation of glycogen phosphorylase in preneoplastic and neoplastic hepatic lesions in rats. Virchows Arch. B (Cell Pathol.)53: 44–51.
57.
SellSHuntJMKnollBJDunsfordHA (1987). Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Adv. Cancer Res.48: 37–111.
58.
SquireRALevittMH (1975). Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res.35: 3214–3223.
59.
StewartHLWilliamsGKeysserCHLombardLSMontaliRJ (1980). Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst.65: 179–206.
60.
TatematsuMAokiTKagawaMMeraYItoN (1988). Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis9: 221–225.
61.
TatematsuMMeraYInoueTSatohKSatoKItoN (1988). Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of γ-glutamyltransferase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis.215–220.
62.
TsaoMSGrishamJW (1987). Hepatocarcinomas, cholangiocarcinomas and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells. Am. J. Pathol.127: 168–181.
63.
WansonJCBernaertDPenasseWMosselmansRBannaschP (1980). Separation in distinct sub-populations by elutriation of liver cells following exposure of rats to N-nitrosomorpholine. Cancer Res.40: 459–471.
64.
WardJM (1984). Morphology of potential preneoplastic hepatocyte lesions and liver tumors in mice and a comparison with other species. In: Mouse Liver Neoplasia, PoppJA (ed). Hemisphere Publishing Corporation, Washington, New York, London, pp. 1–26.
65.
WeberE (1989). Dosisabhängigkeit der Sequenz zellulärer Veränderungen bei der N-Nitrosomorpholin-$induzierten Hepatokarzinogenese in der Ratte. Thesis (T.H. Darmstadt).
66.
WeberEMooreMABannaschP (1988). Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis9: 1049–1054.
67.
WilliamsGM (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim. Biophys. Acta605: 167–189.
68.
WilliamsGM (1982). Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters. Toxicol. Pathol.10: 3–10.
69.
ZerbanHPreussmannRBannaschP (1988). Dose-time-relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Carcinogenesis9: 607–610.
70.
ZerbanHPreussmannRBannaschP (1988). Quantitative morphometric comparison between the expression of two different “marker enzymes” in preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Cancer Lett.43: 99–104.
71.
ZerbanHRabesHMBannaschP (1989). Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis. J. Cancer Clin. Oncol.115: 329–334.
